Dr. Yu-Wei Lin (Australia)
Dr. Yu-Wei Lin is a passionate clinical researcher/pharmacometrician whose long-term career goal is to make pioneering break-through discoveries in the treatment of life-threatening infections caused by pandrug-resistant Gram-negative pathogens. Yu-Wei holds a PhD in PharmSci from the University of Sydney and a double degree in PharmD (first class honours) and PharmSci from the University of South Australia. Yu-Wei has published 50+ publications to date and has presented his research both nationally and internationally at various conferences, including the AAPS Conference (2017). Yu-Wei was a finalist in the Monash Industry Pitch Competition (2018), a recipient of the Ted Martonen Research Award (2017), AAPS Graduate Student Award in PK/PD, and Clinical Pharmacology and Translational Research (2017), Royal Society of NSW Graduate Student Award (2017), ISAM Best Oral Presentation Award (2017), Lion Club Research Awards (2018-2019), Monash Bridging Fellowship Award (2018) and ASCEPT Young Investigator Award (2019). His research is well-funded, having received over AUD 1.5 million from international agencies such as the US NIH and the Australian NHMRC. Dr. Lin has garnered industry experience in model-informed drug discovery and development (MIDD) and currently serves as the Director of Pharmacometrics at Certara. Over the past two years, he has contributed to more than 50 MID3 projects across various disease areas.
Dr. Yu-Wei Lin is a passionate clinical researcher/pharmacometrician whose long-term career goal is to make pioneering break-through discoveries in the treatment of life-threatening infections caused by pandrug-resistant Gram-negative pathogens. Yu-Wei holds a PhD in PharmSci from the University of Sydney and a double degree in PharmD (first class honours) and PharmSci from the University of South Australia. Yu-Wei has published 50+ publications to date and has presented his research both nationally and internationally at various conferences, including the AAPS Conference (2017). Yu-Wei was a finalist in the Monash Industry Pitch Competition (2018), a recipient of the Ted Martonen Research Award (2017), AAPS Graduate Student Award in PK/PD, and Clinical Pharmacology and Translational Research (2017), Royal Society of NSW Graduate Student Award (2017), ISAM Best Oral Presentation Award (2017), Lion Club Research Awards (2018-2019), Monash Bridging Fellowship Award (2018) and ASCEPT Young Investigator Award (2019). His research is well-funded, having received over AUD 1.5 million from international agencies such as the US NIH and the Australian NHMRC. Dr. Lin has garnered industry experience in model-informed drug discovery and development (MIDD) and currently serves as the Director of Pharmacometrics at Certara. Over the past two years, he has contributed to more than 50 MID3 projects across various disease areas.